Omthera Pharmaceuticals Inc. announced that it has priced its initial public offering of 8.00 million shares of its common stock at $8.00 per share. According to recent regulatory filings, the company planned to offer about 5.77 million shares in the range of $12.00 to $14.00 per share.
In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1.20 million shares of common stock. The shares of Omthera's common stock will trade on the NASDAQ Global Market under the symbol "OMTH" beginning on April 11, 2013. All shares of common stock were offered by Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular disease.
For comments and feedback: editorial@rttnews.com